The first dose is usually 1000 mcg weekly
mild injection-site reactions were the only notable adverse events, with no changes to glucose or hormone panels
AOD9604 is studied for stimulating fat breakdown specifically, without the bone growth, muscle growth, or insulin resistance effects typically associated with full-length growth hormone administration
Reliability to operate Create certainty and peace of mind for operators, production managers, and management with transparent information available to all
This program is ideal for individuals who: Are on a weight loss program and want to accelerate their results
Its the simplest, most accessible thing we do and for the right patient, its also one of the most genuinely felt